cagrisema phase 3 results 2024 2025 semaglutide cagrilintide Achieves 22.7% Weight Loss in REDEFINE 1 Trial Presenters to provide first look
Description
10.1111/jnc.12630 J
A meta-analysis of the five trials that included PPS and placebo arms revealed a statistically significant, but clinically somewhat weak, relative risk ratio of 1.69 (95% confidence interval = 1.16 to 2.46)
Vitamin #B12 deficiency is known to cause anemia, peripheral neuropathy, dementia, psychosis and skin pigmentation
Ehrlich & Hazard 2010)
